Related references
Note: Only part of the references are listed.Pain and purinergic signaling
Makoto Tsuda et al.
BRAIN RESEARCH REVIEWS (2010)
Molecular Background of Leak K+ Currents: Two-Pore Domain Potassium Channels
Peter Enyedi et al.
PHYSIOLOGICAL REVIEWS (2010)
The neural-glial purinergic receptor ensemble in chronic pain states
Michael F. Jarvis
TRENDS IN NEUROSCIENCES (2010)
Analgesic potential of TRPV1 antagonists
Philip R. Kym et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Voltage-gated sodium channels in pain states: Role in pathophysiology and targets for treatment
Sulayman D. Dib-Hajj et al.
BRAIN RESEARCH REVIEWS (2009)
Guide to Receptors and Channels (GRAC), 4th edition
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Subtype-selective targeting of voltage-gated sodium channels
Steve England et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
TRP Channels and Pain
Daniel N. Cortright et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Voltage-Gated Sodium Channel Blockers for the Treatment of Chronic Pain
Mark A. Matulenko et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway
Martin J. Gunthorpe et al.
DRUG DISCOVERY TODAY (2009)
Molecular Biology of Background K Channels: Insights from K2P Knockout Mice
Marta Sabbadini et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Crystal structure of the ATP-gated P2X4 ion channel in the closed state
Toshimitsu Kawate et al.
NATURE (2009)
Robotic multiwell planar patch-clamp for native and primary mammalian cells
Carol J. Milligan et al.
NATURE PROTOCOLS (2009)
Chloride channels as drug targets
Alan S. Verkman et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Transient receptor potential channels: targeting pain at the source
Ardem Patapoutian et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Epilepsy, Ataxia, Sensorineural Deafness, Tubulopathy, and KCNJ10 Mutations.
Detlef Bockenhauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Selective Targeting of TRPV1 Expressing Sensory Nerve Terminals in the Spinal Cord for Long Lasting Analgesia
Joseph A. Jeffry et al.
PLOS ONE (2009)
Capsaicin (TRPV1 agonist) therapy for pain relief - Farewell or revival?
Helena Knotkova et al.
CLINICAL JOURNAL OF PAIN (2008)
Voltage-gated Na+ channels:: Potential for β subunits as therapeutic targets
William J. Brackenbury et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
The M1P1 loop of TASK3 K2P channels apposes the selectivity filter and influences channel function
Catherine E. Clarke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Ion channels as drug targets: The next GPCRs
Gregory J. Kaczorowski et al.
JOURNAL OF GENERAL PHYSIOLOGY (2008)
Inherited Neuronal Ion Channelopathies: New Windows on Complex Neurological Diseases
William A. Catterall et al.
JOURNAL OF NEUROSCIENCE (2008)
Pungent agents from Szechuan peppers excite sensory neurons by inhibiting two-pore potassium channels
Diana M. Bautista et al.
NATURE NEUROSCIENCE (2008)
High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology
John Dunlop et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
TASK channel deletion in mice causes primary hyperaldosteronism
Lucinda A. Davies et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact
Douglas A. Bayliss et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis
Dirk Heitzmann et al.
EMBO JOURNAL (2008)
TRESK two-pore-domain K+ channels constitute a significant component of background potassium currents in murine dorsal root ganglion neurones
Tina Dobler et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
The differential effect of cyclosporine on hypnotic response and pain reaction in mice
Yuki Sato et al.
ANESTHESIA AND ANALGESIA (2007)
From genes to pain:: Nav1.7 and human pain disorders
Sulayman D. Dib-Hajj et al.
TRENDS IN NEUROSCIENCES (2007)
Agonists and antagonists of the cardiac ryanodine receptor: Potential therapeutic agents?
Angela F. Dulhunty et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Neuronal two-pore-domain potassium channels and their regulation by G protein-coupled receptors
Alistair Mathie
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Biophysical, pharmacological, functional characteristics of cloned and native mammalian two-pore domain K+ channels
David P. Lotshaw
CELL BIOCHEMISTRY AND BIOPHYSICS (2007)
Episodic ataxia type 1: A neuronal potassium channelopathy
Sanjeev Rajakulendran et al.
NEUROTHERAPEUTICS (2007)
The hERG potassium channel as a therapeutic target
Harry J. Witchel
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
The neuronal background K-2P channels: focus on TREK1
Eric Honore
NATURE REVIEWS NEUROSCIENCE (2007)
An SCN9A channelopathy causes congenital inability to experience pain
James J. Cox et al.
NATURE (2006)
Opinion - How many drug targets are there?
John P. Overington et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Opinion - Drugs, their targets and the nature and number of drug targets
Peter Imming et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype
Catherine Heurteaux et al.
NATURE NEUROSCIENCE (2006)
Population patch clamp improves data consistency and success rates in the measurement of ionic currents
Alan Finkel et al.
JOURNAL OF BIOMOLECULAR SCREENING (2006)
TREK-2 (K2P10.1) and TRESK (K2P18.1) are major background K+ channels in dorsal root ganglion neurons
Dawon Kang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
TREK-1, a K+ channel involved in polymodal pain perception
Abdelkrim Alloui et al.
EMBO JOURNAL (2006)
Targeting of calcineurin to an NFAT-like docking site is required for the calcium-dependent activation of the background K+channel, TRESK
Gabor Czirjak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
QPatch: the past, present and future of automated patch clamp
C Mathes
EXPERT OPINION ON THERAPEUTIC TARGETS (2006)
hERG potassium channels and cardiac arrhythmia
MC Sanguinetti et al.
NATURE (2006)
Overview of molecular relationships in the voltage-gated ion channel superfamily
FH Yu et al.
PHARMACOLOGICAL REVIEWS (2005)
International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels
SAN Goldstein et al.
PHARMACOLOGICAL REVIEWS (2005)
Crystal structure of a mammalian voltage-dependent Shaker family K+ channel
SB Long et al.
SCIENCE (2005)
Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine
LE Kennard et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Physiology and pharmacology of two-pore domain potassium channels
D Kim
CURRENT PHARMACEUTICAL DESIGN (2005)
TREK-1, a K+ channel involved in neuroprotection and general anesthesia
C Heurteaux et al.
EMBO JOURNAL (2004)
Trends in ion channel drug discovery: advances in screening technologies
PB Bennett et al.
TRENDS IN BIOTECHNOLOGY (2003)
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury
M Tsuda et al.
NATURE (2003)
A novel two-pore domain K+ channel, TRESK, is localized in the spinal cord
Y Sano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
X-ray structure of a voltage-dependent K+ channel
YX Jiang et al.
NATURE (2003)
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
WS Redfern et al.
CARDIOVASCULAR RESEARCH (2003)
M-channels - Neurological diseases, neuromodulation, and drug development
EC Cooper et al.
ARCHIVES OF NEUROLOGY (2003)
IonWorks™ HT:: A new high-throughput electrophysiology measurement platform
K Schroeder et al.
JOURNAL OF BIOMOLECULAR SCREENING (2003)
Crystal structure and mechanism of a calcium-gated potassium channel
YX Jiang et al.
NATURE (2002)
A structural basis for drug-induced long QT syndrome
JS Mitcheson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
